Exact match
Title 21
Title 21 / Chapter 9 FEDERAL FOOD, DRUG, AND COSMETIC ACT / Subchapter V DRUGS AND DEVICES / Part A Drugs and Devices / Section 356–2
Search
Search the current U.S. Code within Title 21
Search by citation or keyword across the current edition within Title 21.
20 results
356-2
Scoped to Title 21
Title 21
Title 21 / Section 356
21 U.S.C. § 356
Expedited approval of drugs for serious or life-threatening diseases or conditions
Expedited approval of drugs for serious or life-threatening diseases or conditions
Title 21
Title 21 / Section 356b
Title 21
Title 21 / Section 356–1
21 U.S.C. § 356–1
Accelerated approval of priority countermeasures
Accelerated approval of priority countermeasures
Title 21
Title 21 / Section 360a–2
21 U.S.C. § 360a–2
Susceptibility test interpretive criteria for microorganisms
Susceptibility test interpretive criteria for microorganisms
Title 21
Title 21 / Section 387r
21 U.S.C. § 387r
Drug products used to treat tobacco dependence
Drug products used to treat tobacco dependence
Title 21
Title 21 / Section 356g
21 U.S.C. § 356g
Standards for regenerative medicine and regenerative advanced therapies
Standards for regenerative medicine and regenerative advanced therapies
Title 21
Title 21 / Section 1701
Title 21
Title 21 / Section 357
Title 21
Title 21 / Section 360bbb–0
21 U.S.C. § 360bbb–0
Expanded access policy required for investigational drugs
Expanded access policy required for investigational drugs
Title 21
Title 21 / Section 360bbb–3c
21 U.S.C. § 360bbb–3c
Expedited development and review of medical products for emergency uses
Expedited development and review of medical products for emergency uses
Title 21
Title 21 / Section 1705
21 U.S.C. § 1705
Development, submission, implementation, and assessment of National Drug Control Strategy
Development, submission, implementation, and assessment of National Drug Control Strategy
Title 21
Title 21 / Section 301
Title 21
Title 21 / Section 321
Title 21
Title 21 / Section 352
Title 21
Title 21 / Section 360
21 U.S.C. § 360
Registration of producers of drugs or devices
Registration of producers of drugs or devices
Title 21
Title 21 / Section 360d
Title 21
Title 21 / Section 360ff
21 U.S.C. § 360ff
Priority review to encourage treatments for rare pediatric diseases
Priority review to encourage treatments for rare pediatric diseases
Title 21
Title 21 / Section 360ii
Title 21
Title 21 / Section 360bbb–4
21 U.S.C. § 360bbb–4
Countermeasure development, review, and technical assistance
Countermeasure development, review, and technical assistance